Drug-resistant TB cases may spike in India by 2040
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
A new study has found that India could witness an alarming spike in cases of drug-resistant tuberculosis in the next two decades. According to the study, published in the prestigious Lancet medical journal, drug-resistant TB could make up one in ten cases of the disease in the country by 2040. A similar spike has been forecast for Philippines, Russia, and South Africa too.

Tuberculosis is a bacterial disease that can be treated with a combination of antibiotic drugs. However, the “use and misuse” of antibiotics — such as using the wrong drug, or not completing the full course of treatment — may result in bacteria developing drug resistance, known as acquired drug resistance. The study said the upturn is likely because of increased transmission of drug-resistant tuberculosis between people, rather than by strains acquiring resistance to drugs. While better access to treatment programmes will reduce rates of drug-resistant TB in the aforementioned countries, they alone will not eradicate the problem as current efforts may not be enough to reverse the spike.

http://indianexpress.com/article/india/drug-resistant-tb-cases-may-spike-in-india-by-2040-4648854/
Preview
Like
Comment
Share